TrialClinical pharmacokinetics2020

Cost-Neutral Optimization of Pazopanib Exposure by Splitting Intake Moments: A Prospective Pharmacokinetic Study in Cancer Patients.

Stefanie L Groenland et al.PubMed ↗Publisher ↗

No numbers read from the abstract.